The metabolic enhancement from glucagon activation combined with appetite suppression from GLP-1 and potential fat distribution benefits from GIP creates multiple layers of weight regulation support
OX 1 R exhibits an order of magnitude higher affinity for orexin A compared to orexin B whereas OX 2 R has been shown to bind both peptides with equal affinity
Individual factors such as metabolic rate, hormonal adaptation, and dietary habits can also reduce the medication's appetite-suppressing effect
Unfortunately, the results seen from anti-amyloid (plaque buster) clinical trials have been disappointing [9]
Some users take higher doses up to 2000 mcg daily without reported issues
In some women, these androgens can: Cause hair follicles to shrink (miniaturize) Shorten the hair growth cycle Lead to progressively thinner hair Result in female pattern hair loss (androgenetic alopecia) This is particularly common in women with: Polycystic ovary syndrome (PCOS) High androgen levels Hormonal changes during or after menopause Genetic sensitivity to androgens How Spironolactone Works: Spironolactone addresses hair loss through anti-androgen activity: Blocks Androgen Receptors: Prevents androgens like testosterone and DHT from binding to receptors in hair follicles, reducing their harmful effects on hair growth